SMG9 Serves as an Oncogene to Promote the Tumor Progression via EMT and Wnt/ β-Catenin Signaling Pathway in Hepatocellular Carcinoma

Conclusions: SMG9 may serve as a potential novel prognostic biomarker and therapeutic target in HCC patients.
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research